The DOI matches its Crossref record; the references it cites are not checked yet.
Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy?
Open accessAbstract
It is now evident that elevated circulating levels of triglycerides in the non-fasting state, a marker for triglyceride (TG)-rich remnant particles, are associated with increased risk of premature cardiovascular disease (CVD). Recent findings from basic and clinical studies have begun to elucidate the mechanisms that contribute to the atherogenicity of these apoB-containing particles. Here, we review current knowledge of the formation, intravascular remodelling and catabolism of TG-rich lipoproteins and highlight (i) the pivotal players involved in this process, including lipoprotein lipase, glycosylphosphatidylinositol HDL binding protein 1 (GPIHBP1), apolipoprotein (apo) C-II, apoC-III, angiopoietin-like protein (ANGPTL) 3, 4 and 8, apoA-V and cholesteryl ester transfer protein; (ii) key determinants of triglyceride (TG) levels and notably rates of production of very-low-density lipoprotein 1 (VLDL1) particles; and (iii) the mechanisms which underlie the atherogenicity of remnant particles. Finally, we emphasise the polygenic nature of moderate hypertriglyceridemia and briefly discuss modalities for its clinical management. Several new therapeutic strategies to attenuate hypertriglyceridemia have appeared recently, among which those targeted to apoC-III appear to hold considerable promise.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Remnant particles are enriched in cholesteryl esters and deficient in TG (Figure 2).”
The cited source says what the claim attributes to it.
In the citing paper
“Apo C-III is expressed both intestinally and hepatically, circulates with TG-rich lipoproteins, has net deleterious effects on lipoprotein metabolism58–63”
From Clinical review on triglycerides (2020) · cites this paper as [62]
In the citing paper
“Hepatic clearance of VLDL remnants is mediated by either apoB100 or apoE through receptor-dependent and receptor-independent pathways;7,17,71,73 25–75% of these particles are removed directly rather than converted to LDL.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 94 · Cited by 90
Research works printed but not linked: 1
- Taskinen MR, Adiels M, Westerbacka J, et al. Dual metabolic defects are required to produce hypertriglyceridemia in obese subjects. Arterioscler Thromb Vasc Biol. 2011;31:2144–50. · DOI · Paper page
Metadata
- Authors
- Dallinga-Thie, G. M., Kroon, J., Borén, J., & Chapman, M. J.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Sahlgrenska University Hospital (SE)
- Inserm (FR)
- Venue
- Current Cardiology Reports
- Published
- 2016-05-23
- Volume
- 18
- Issue
- 7
- Pages
- 67-67
- ISSN
- 1523-3782 (ISSN-L)
- 1534-3170
- PMC
- PMC4877422
- OpenAlex
- W2398962077
- Cited by
- 90
- References
- 94
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 4 · 2023: 9 · 2022: 6 · 2021: 14 · 2020: 11 · 2019: 11 · 2018: 17 · 2017: 6 · 2016: 1
- FWCI
- 2.03
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Current Cardiology Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- triglyceride-rich lipoproteins, hypertriglyceridemia, atherogenicity, cardiovascular risk, lipoprotein lipase, GPIHBP1, apolipoprotein C-II, apolipoprotein C-III, ANGPTL3, ANGPTL4, ANGPTL8, apolipoprotein A-V, cholesteryl ester transfer protein
- MeSH terms
- Hypolipidemic Agents, Cholesterol, Endothelium, Vascular, Humans, Lipoproteins, Triglycerides, Hypertriglyceridemia, Postprandial Period, Atherosclerosis, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy? https://app.cochat.ai/papers/10.1007/s11886-016-0745-6
- The paper
- Dallinga-Thie, G. M., Kroon, J., Borén, J., & Chapman, M. J. (2016). Triglyceride-Rich Lipoproteins and Remnants: Targets for Therapy? Current Cardiology Reports. https://doi.org/10.1007/s11886-016-0745-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.